These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 28438502)

  • 21. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.
    Annane D; Vignon P; Renault A; Bollaert PE; Charpentier C; Martin C; Troché G; Ricard JD; Nitenberg G; Papazian L; Azoulay E; Bellissant E;
    Lancet; 2007 Aug; 370(9588):676-84. PubMed ID: 17720019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selepressin, a novel selective vasopressin V
    Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
    Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Editors' comments on a new trial of activated protein C for persistent septic shock.
    Mancebo J; Antonelli M
    Intensive Care Med; 2008 Nov; 34(11):1948-9. PubMed ID: 18839138
    [No Abstract]   [Full Text] [Related]  

  • 24. Is vasopressin increasing or decreasing mortality in patients with septic shock?
    Rehberg S; Ertmer C; Van Aken H; Westphal M
    Surg Infect (Larchmt); 2008 Apr; 9(2):215 author reply 216. PubMed ID: 18426355
    [No Abstract]   [Full Text] [Related]  

  • 25. Woman dies after infection with bacteria resistant to all antibiotics available in US.
    McCarthy M
    BMJ; 2017 Jan; 356():j254. PubMed ID: 28096073
    [No Abstract]   [Full Text] [Related]  

  • 26. Benefits of ethyl gallate versus norepinephrine in the treatment of cardiovascular collapse in Pseudomonas aeruginosa septic shock in dogs.
    Gotes J; Kasian K; Jacobs H; Cheng ZQ; Mink SN
    Crit Care Med; 2012 Feb; 40(2):560-72. PubMed ID: 22020237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
    Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
    Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
    Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
    J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock.
    Nakada TA; Russell JA; Boyd JH; Aguirre-Hernandez R; Thain KR; Thair SA; Nakada E; McConechy M; Walley KR
    Am J Respir Crit Care Med; 2010 Jan; 181(2):143-9. PubMed ID: 19850944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Effectiveness of Second Vasoactive Agents in Septic Shock Refractory to Norepinephrine.
    Nguyen HB; Lu S; Possagnoli I; Stokes P
    J Intensive Care Med; 2017 Aug; 32(7):451-459. PubMed ID: 27189952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasopressin in septic shock: clinical equipoise mandates a time for restraint.
    Russell JA
    Crit Care Med; 2003 Nov; 31(11):2707-9. PubMed ID: 14605551
    [No Abstract]   [Full Text] [Related]  

  • 32. [A clinical study of pituitrin versus norepinephrine in the treatment of patients with septic shock].
    Han XD; Sun H; Huang XY; Zhang SY; Wang YD; Ren K; Li F
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jan; 24(1):33-7. PubMed ID: 22248749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxic shock syndrome in the United States: surveillance update, 1979 1996.
    Hajjeh RA; Reingold A; Weil A; Shutt K; Schuchat A; Perkins BA
    Emerg Infect Dis; 1999; 5(6):807-10. PubMed ID: 10603216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breakthrough topics in severe infections.
    Carlet J
    Curr Opin Crit Care; 2008 Oct; 14(5):579. PubMed ID: 18787452
    [No Abstract]   [Full Text] [Related]  

  • 35. Predictors of prolonged vasopressin infusion for the treatment of septic shock.
    Personett HA; Stollings JL; Cha SS; Oyen LJ
    J Crit Care; 2012 Jun; 27(3):318.e7-12. PubMed ID: 22227078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No good deed goes unpunished!
    Ayala A; Wesche-Soldato DE; Garber M; Swan R; Perl M
    Intensive Care Med; 2006 May; 32(5):637-8. PubMed ID: 16583220
    [No Abstract]   [Full Text] [Related]  

  • 37. Vasopressin and its immune effects in septic shock.
    Russell JA; Walley KR
    J Innate Immun; 2010; 2(5):446-60. PubMed ID: 20606409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of a recent chemotherapy on the duration and intensity of the norepinephrine support during septic shock.
    Schnell D; Besset S; Lengliné E; Maziers N; Zafrani L; Reuter D; Moreau AS; Canet E; Lemiale V; Azoulay E
    Shock; 2013 Feb; 39(2):138-43. PubMed ID: 23324882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
    Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
    Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Science, medicine and industry: are we getting out of the black hole in sepsis research?
    Suter PM; Takala J
    Intensive Care Med; 2008 Nov; 34(11):1950-4. PubMed ID: 18839139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.